A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial

(2018) Lutz Heinemann et al.   LANCET

Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom

(2017) Barnaby Hunt et al.   Diabetes Therapy

Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom

(2017) Barnaby Hunt et al.   Diabetes Therapy

Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit

(2016) M. Baxter et al.   DIABETIC MEDICINE

Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases

(2016) Aveni Haynes et al.   PEDIATRIC DIABETES

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)

(2015) M. L. Alva et al.   DIABETIC MEDICINE

Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31 330 young patients with type 1 diabetes

(2015) Beate Karges et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study

(2015) Mike Gillett et al.   HEALTH TECHNOLOGY ASSESSMENT

Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion

(2014) R. Nixon et al.   DIABETIC MEDICINE

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

(2014) H. A. Dakin et al.   BMJ Open

Clinical and socio-demographic factors associated with diabetic ketoacidosis hospitalization in adults with Type 1 diabetes

(2013) S. Butalia et al.   DIABETIC MEDICINE

A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis

(2013) C. Andy Schuetz et al.   PLoS One

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

(2012) N. Hex et al.   DIABETIC MEDICINE

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

(2010) J. W. Albers et al.   DIABETES CARE

Rates of Progression in Diabetic Retinopathy During Different Time Periods: A systematic review and meta-analysis

(2009) T. Y. Wong et al.   DIABETES CARE

Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection

(2009) M. Franciosi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Costs of managing severe hypoglycaemia in three European countries

(2009) Mette Hammer et al.   JOURNAL OF MEDICAL ECONOMICS

Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes

(2008) J. Geddes et al.   DIABETIC MEDICINE

Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

(2008) J. C. Pickup et al.   DIABETIC MEDICINE